It was actually "in excess of $200,000.00" from 3 customers
"BioElectronics Corporation is pleased to announce that it has signed two additional international distribution partners and received a new order from its longtime distribution partner in Bangladesh, Multiple Health Pharma, Ltd., who has resumed operations following shutdowns due to Covid. These two new international orders and the renewal order total in excess of $200,000.00."
"The first new order comes from Stada MENA DWC-LLC. It will be distributing ActiPatch in Bahrain and the Kingdom of Saudi Arabia. Erin Sanders, International Sales Manager for BioElectronics, said, “After lengthy negotiations and delays due to Covid, I am pleased to close the contract and bring on this well qualified and capable distribution partner.” "
"Ms. Sanders has also finalized a contract with Modern Development Medical Company., which will be distributing both RecoveryRx and ActiPatch in Kuwait, Qatar, and Oman. In the United Arab Emirates, they will be focusing on the RecoveryRx brand. "
This was stated on 2/28, 31 days before the end of Q1, and was not stated as a total to that date, just a snap shot of 3 International orders.
As far as Amazon goes, BIEL has already recognized the revenue from the devices being sold on Amazon. It matters because every device sold brings KT closer to their reorder point.
As far as, "has been a lot higher than #78", we got a daily, sometimes hourly, announcement when the Wave was out of the 'Top 100' and silence from the same source when sales increases moved KT back to the 'Top 100'. So unless one complained about the 'out of the top 100' announcements .......
